Skip to main content


What's new

On February 8, Novo Nordisk received an FDA complete response letter (CRL) for Tresiba (insulin degludec) and... Continue Reading »

What’s an SGLT-2 inhibitor and how does it work? Includes cool FAQ! Continue Reading »

The Centers for Disease Control and Prevention (CDC)... Continue Reading »

On November 29, NeuroMetrix announced that it had cleared the final hurdle holding up the introduction of the Sensus... Continue Reading »

diaTribe’s remarkable board of diabetes experts on what every person with diabetes must know. Plus, what can we look forward to in the next five years? Continue Reading »

In time for the beginning of this school year, DC Public Schools (DCPS) took a major step toward providing access to... Continue Reading »